These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 30216436)

  • 1. Oncologist volume and outcomes in older adults diagnosed with diffuse large B cell lymphoma.
    Huntington SF; Hoag JR; Zhu W; Wang R; Zeidan AM; Giri S; Podoltsev NA; Gore SD; Ma X; Gross CP; Davidoff AJ
    Cancer; 2018 Nov; 124(21):4211-4220. PubMed ID: 30216436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variation in receipt of therapy and survival with provider volume for medical oncology in non-curative esophago-gastric cancer: a population-based analysis.
    Hallet J; Davis LE; Mahar AL; Liu Y; Zuk V; Gupta V; Earle CC; Coburn NG
    Gastric Cancer; 2020 Mar; 23(2):300-309. PubMed ID: 31628561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Preexisting Heart Failure With Outcomes in Older Patients With Diffuse Large B-Cell Lymphoma.
    Upshaw JN; Nelson J; Rodday AM; Kumar AJ; Klein AK; Konstam MA; Wong JB; Jaffe IZ; Ky B; Friedberg JW; Maurer M; Kent DM; Parsons SK
    JAMA Cardiol; 2023 May; 8(5):453-461. PubMed ID: 36988926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of diffuse large B-cell lymphoma on visits to different provider specialties among elderly Medicare beneficiaries: challenges for care coordination.
    Garg R; Sambamoorthi U; Tan X; Basu SK; Haggerty T; Kelly KM
    Transl Behav Med; 2018 May; 8(3):386-399. PubMed ID: 29370438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiologic, prognostic, and treatment factors in sinonasal diffuse large B -cell lymphoma.
    Varelas AN; Eggerstedt M; Ganti A; Tajudeen BA
    Laryngoscope; 2019 Jun; 129(6):1259-1264. PubMed ID: 30570148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment patterns and comparative effectiveness in elderly diffuse large B-cell lymphoma patients: a surveillance, epidemiology, and end results-medicare analysis.
    Hamlin PA; Satram-Hoang S; Reyes C; Hoang KQ; Guduru SR; Skettino S
    Oncologist; 2014 Dec; 19(12):1249-57. PubMed ID: 25342313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and Predictors of Palliative Care Utilization among Hospitalized Patients with Diffuse Large B-Cell Lymphoma.
    Jackson I; Etuk A; Jackson N
    J Palliat Care; 2023 Apr; 38(2):167-174. PubMed ID: 35006019
    [No Abstract]   [Full Text] [Related]  

  • 8. Functional status and therapy for older adults with diffuse large B-cell lymphoma in nursing homes: A population-based study.
    Di M; Keeney T; Belanger E; Huntington SF; Olszewski AJ; Panagiotou OA
    J Am Geriatr Soc; 2023 Jul; 71(7):2239-2249. PubMed ID: 36882865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterizing Autoimmune Disease-associated Diffuse Large B-cell Lymphoma in a SEER-Medicare Cohort.
    Koff JL; Rai A; Flowers CR
    Clin Lymphoma Myeloma Leuk; 2018 Feb; 18(2):e115-e121. PubMed ID: 29273217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disease characteristics, patterns of care, and survival in very elderly patients with diffuse large B-cell lymphoma.
    Williams JN; Rai A; Lipscomb J; Koff JL; Nastoupil LJ; Flowers CR
    Cancer; 2015 Jun; 121(11):1800-8. PubMed ID: 25675909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Second-line therapy in diffuse large B-cell lymphoma (DLBCL): treatment patterns and outcomes in older patients receiving outpatient chemotherapy.
    Danese MD; Griffiths RI; Gleeson ML; Dalvi T; Li J; Mikhael JR; Deeter R; Dreyling M
    Leuk Lymphoma; 2017 May; 58(5):1094-1104. PubMed ID: 27659997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparative population-based analysis of sinonasal diffuse large B-cell and extranodal NK/T-cell lymphomas.
    Dubal PM; Dutta R; Vazquez A; Patel TD; Baredes S; Eloy JA
    Laryngoscope; 2015 May; 125(5):1077-83. PubMed ID: 25546466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Global Risk Indicator and Therapy for Older Patients With Diffuse Large B-Cell Lymphoma: A Population-Based Study.
    Di M; Keeney T; Belanger E; Panagiotou OA; Olszewski AJ
    JCO Oncol Pract; 2022 Mar; 18(3):e383-e402. PubMed ID: 34846916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Venous-thromboembolism and associated health care utilization in elderly patients with diffuse large B cell lymphoma.
    Gangaraju R; Davis ES; Bhatia S; Kenzik KM
    Cancer; 2022 Jun; 128(12):2348-2357. PubMed ID: 35363373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C-MYC-positive relapsed and refractory, diffuse large B-cell lymphoma: Impact of additional "hits" and outcomes with subsequent therapy.
    Epperla N; Maddocks KJ; Salhab M; Chavez JC; Reddy N; Karmali R; Umyarova E; Bachanova V; Costa C; Glenn M; Calzada O; Xavier AC; Zhou Z; Hossain NM; Hernandez-Ilizaliturri FJ; Al-Mansour Z; Barta SK; Chhabra S; Lansigan F; Mehta A; Jaglal MV; Evens AM; Flowers CR; Cohen JB; Fenske TS; Hamadani M; Costa LJ
    Cancer; 2017 Nov; 123(22):4411-4418. PubMed ID: 28749548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Presence of a high-grade component in gastric mucosa-associated lymphoid tissue (MALT) lymphoma is not associated with an adverse prognosis.
    Ang MK; Hee SW; Quek R; Yap SP; Loong S; Tan L; Tao M; Lim ST
    Ann Hematol; 2009 May; 88(5):417-24. PubMed ID: 18777110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physician Experience and Risk of Rituximab Discontinuation in Older Adults With Non-Hodgkin's Lymphoma.
    Huntington SF; Hoag JR; Wang R; Zeidan AM; Giri S; Gore SD; Ma X; Gross CP; Davidoff AJ
    J Natl Compr Canc Netw; 2019 Oct; 17(10):1194-1202. PubMed ID: 31590152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Racial differences in treatment and survival in older patients with diffuse large B-cell lymphoma (DLBCL).
    Griffiths R; Gleeson M; Knopf K; Danese M
    BMC Cancer; 2010 Nov; 10():625. PubMed ID: 21073707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of center type and socioeconomic factors on early mortality and overall survival of diffuse large B-cell lymphoma.
    Dhakal P; Chen B; Giri S; Vose JM; Armitage JO; Bhatt VR
    Future Oncol; 2019 Jun; 15(18):2113-2124. PubMed ID: 31144521
    [No Abstract]   [Full Text] [Related]  

  • 20. Sites of extranodal involvement are prognostic in patients with diffuse large B-cell lymphoma in the rituximab era: an analysis of the Surveillance, Epidemiology and End Results database.
    Castillo JJ; Winer ES; Olszewski AJ
    Am J Hematol; 2014 Mar; 89(3):310-4. PubMed ID: 24273125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.